Article information
Full text is only aviable in PDF
Bibliografía
[1.]
I.Y. Adamson, D.H. Bowden.
Endothelial injury and repair radiation-induced pulmonary fibrosis.
Am J Pathol, 112 (1983), pp. 224-230
[2.]
G.L. Snider, J.A. Hayes, et al.
Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomyc pathology serology.
Am Rev Respir Dis, 117 (1978), pp. 1.099-1.108
[3.]
P. Smith, D. Heath, et al.
The pathogenesis and structure of paraquat-induced pulmonary fibrosis in rats.
J Pathol, 114 (1974), pp. 57-67
[4.]
A.L. Katzenstein.
Pathogenesis of “fibrosis” in interstitial pneumonia: An electronmicroscopy study.
Hum Pathol, 16 (1985), pp. 1.015-1.024
[5.]
G. Raghu, L. Striker, et al.
Extracellular matrix in normal and fibrotic human lungs.
Am Rev Respir Dis, 131 (1985), pp. 182-189
[6.]
B.C. Starcher, C. Kuhn, et al.
Increased elastin and collagen content of the lungs of hamsters receiving an intratracheal injection of bleomycin.
Am Rev Respir Dis, 117 (1978), pp. 299-305
[7.]
J.B. Kavlinsky.
Glycosaminoglicans in emphysematous and fibrotic hamster lungs.
Am Rev Respir dis, 125 (1982), pp. 85-86
[8.]
R.S. Thrall, R.W. Barton, et al.
Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during the development of bleomycin-induced pulmonary fibrosis in the rat.
Am Rev Respir Dis, 126 (1982), pp. 488-492
[9.]
E. Fassle.
Pathogenesis of pulmonary fibrosis induced by chrysotile asbestos Longitudinal light and electron microscopic studies on the rat model.
Virchows Archiv A, 408 (1986), pp. 329-346
[10.]
W.M. Haschek, A.J.P. Kelin-Szanto, et al.
Long-term morphologic and biochemical features of experimentally-induced lung fibrosis in the mouse.
Lab Invest, 46 (1982), pp. 438-449
[11.]
Y. Fukuda, V.J. Ferrans, et al.
Patterns of pulmonary structural remodelling following experimental paraquat toxicity: the morphogenesis of intraalveolar fibrosis.
Am J Pathol, 118 (1985), pp. 452-475
[12.]
C.F. Brown, P.C. Prath, et al.
Characterization of pulmonary cellular influx differentials to known toxic agents between species.
Inflammation, 6 (1982), pp. 327-341
[13.]
R.S.N. Somayajulu, S. Mukherjee, et al.
Pulmonary oxygen toxicity in chickens and rabbits.
Undersea Biomed, 5 (1978), pp. 1-7
[16.]
H. Mensing, B.M. Czarnetzki.
Leukotriene B4 induces in vitro fibroblast chemotaxis.
J Invest Dermat, 82 (1984), pp. 9-12
[17.]
E.J. Campbell, R.M. Senior, et al.
Extracellular matrix injury during lung inflammation.
Chest, 92 (1987), pp. 161-167
[18.]
P.B. Bitterman, S.I. Rennard, et al.
Human alveolar macrophage growth factor for fibroblasts: regulation and partial characterization.
J Clin Invest, 70 (1982), pp. 806-822
[19.]
H. Seppa, G. Grotendorst, et al.
Platelet-derived growth factor is chemotactic for fibroblasts.
J Cell Biol, 92 (1982), pp. 584-588
[20.]
E.A. Bauer, T.W. Cooper, et al.
Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor.
Proc Natl Acad Sci USA, 82 (1985), pp. 4.152-4.156
[21.]
M.B. Sporn, A.B. Roberts, et al.
Transforming growth factor P:biological function and Chemical structure.
Science, 233 (1986), pp. 532-534
[22.]
A.E. Postlethwaite, Keski-Oja, et al.
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β.
J Exp Med, 165 (1987), pp. 251-256
[23.]
J. Varga, J. Rosenbloom, et al.
Transforming growth factor p (TGF-β) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNA's in normal human dermal fíbroblasts.
Biochem, 247 (1987), pp. 597-604
[24.]
C.J. Roberts, T.M. Birkenmeir, et al.
Transforming growth factor P stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor for cultured human lung fíbroblasts.
J Biol Chem, 236 (1988), pp. 4.585-4.592
[25.]
B.J. Sugarman, B.B. Aggarwal, et al.
Recombinant human tumor necrosis factor a Effects on proliferation of normal and transformed cells in vitro.
Science (Wash. DC), 280 (1985), pp. 943-945
[26.]
J.M. Dayer, B. Beutler, et al.
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production for human synovial cells and dermal fíbroblasts.
J Exp Med, 162 (1985), pp. 2.163-2.168
[27.]
J.A. Elias, R.C. Krol, et al.
Regulation of human lung fibroblast glycosaminoglican production by recombinant interferon, tumor necrosis factor and lymphotoxin.
J Clin Invest, 82 (1988), pp. 325-333
[28.]
L.R. Lamontagne, J. Gauldie, et al.
In vivo initiation of unstimulated in vitro interleukin-1 release by alveolar macrophages.
Am Rev Respir Dis, 131 (1985), pp. 326-330
[29.]
M. Jordana, C. Richards, et al.
Spontaneous in vitro release of alveolar macrophage cytokines after the intratracheal administration. of bleomycin in rats: characterization and kinetic studies.
Am Rev Respir Dis, 137 (1988), pp. 1.135-1.140
[30.]
C.A. Dinarello.
An update on human interleukin-1: from molecular biology to clinical relevance.
J Clin Immunol, 5 (1985), pp. 287-296
[31.]
J. Gauldie, C. Richards, et al.
Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocytestimulating factor and regulates the major acute phase protein response in liver cells.
Proc Natl Acad Sci USA, 84 (1987), pp. 7.451-7.455
[32.]
K. Yamauchi, Y. Martinet, et al.
Modulation of fibronectin gene expression in human mononuclear phagocyts.
J Clin Invest, 80 (1987), pp. 1.720-1.727
[33.]
R.G. Crystal, P.B. Bitterman, et al.
Interstitial lung diseases of unknown cause (First of two parts).
N Eng J Med, 310 (1984), pp. 154-160
[34.]
R.H. Goldstein, A. Fine.
Fibrotic reactions in the lung: the activation of the lung fibroblast.
Exp Lung Res, 11 (1986), pp. 245-261
[35.]
C.G. Elliot, A.H. Morris, et al.
Pulmonary function and exercise gas exchange in survivors of adult respiratory distress syndrome.
Am Rev Respir Dis, 123 (1981), pp. 492-495
[36.]
P.D. Potgieter, E. Rosenthal, et al.
Immediate and long-term survival in patients admitted to a respiratory ICU.
Crit Care Med, 13 (1985), pp. 798-802
[37.]
J. Yahav, P. Lieberman, et al.
Pulmonary function following the adult respiratory distress syndrome.
Chest, 74 (1978), pp. 247-250
[38.]
H.H. Rotman, T.F. Lavelle, et al.
Long-term physiologic consequences of the adult respiratory distress syndrome.
Chest, 72 (1977), pp. 190-192
[39.]
M.W. Peterson, M. Monick, et al.
Prognostic role of eosinophils in pulmonary fibrosis.
Chest, 92 (1987), pp. 51-56
[40.]
O. Kawanami, V.J. Ferrans, et al.
Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders.
Lab Invest, 40 (1979), pp. 717-734
[41.]
T. Goto, D.A. Befus, et al.
Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis of rats.
Am Rev Respir Dis, 130 (1984), pp. 797-802
[42.]
M.M.F. Wagner, R.E. Edwards, et al.
Mast cells and inhalation of asbestos in rats.
Thorax, 39 (1984), pp. 539-544
[43.]
S. Watanabe, K. Watanabe, et al.
Mast cells in the rat alveolar septa undergoing fibrosis after ionising radiation.
Lab Invest, 31 (1974), pp. 555-561
[44.]
E.S. Schulman, M.C. Liu, et al.
Human lung macrophages induce histamine release from basophils and mast cells.
Am Rev Respir Dis, 131 (1985), pp. 230-235
[45.]
M. Jordana, A.D. Befus, et al.
Effect of histamine on proliferation of normal human adult lung fíbroblasts.
Thorax, 43 (1988), pp. 552-558
[46.]
F.M. Atkins, D.D. Metcalfe.
Degradation of the heparin matrix of mast cells granules by cultures fíbroblasts.
J Immunol, 131 (1983), pp. 1.420-1.425
[47.]
V. Pilarisetti, Subba Rao, et al.
Phagocytosis of mast cell granules by cultured fíbroblasts.
J Immunol, 130 (1982), pp. 341-349
[48.]
H.N. Claman.
Mast cells T cells and abnormal fibrosis.
Immunology Today, 6 (1985), pp. 192-195
[49.]
D. Metclaf.
The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.
Blood, 67 (1986), pp. 257-267
[50.]
G.C. Bagby, McCall, et al.
A monokine regulates CSA production by vascular endothelial cells.
Blood, 62 (1983), pp. 663-668
[51.]
G.C. Babby, V.D. Rigas, et al.
Interaction of lactoferrin, monocytes and T-lymphocytes subsets in the regulation of steady-state granulopoiesis in vitro.
J Clin Invest, 68 (1981), pp. 56-63
[52.]
M. Lee, G.M. Segal, et al.
Interleukin-1 induces human bone marrow-derived fíbroblasts to produce multilineage hematopoietic growth factors.
Exp Hematol, 15 (1987), pp. 983-988
[53.]
K. Kaushansky, N. Lin, et al.
Interleukin-1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colonystimulating factors.
J Clin Invest, 81 (1988), pp. 92-97
[54.]
J.R. Zucali, H.E. Broxmeyer, et al.
Recombinant human tumor necrosis factors α and β stimulate fibroblasts to produce hemopoietic growth factors in vitro.
J Immunol, 140 (1988), pp. 840-844
[55.]
L. Kobzik, R. Rose.
Alveolar macrophage response to recombinant colony-stimulating factors.
Am Rev Respir Dis, 137 (1988), pp. A38
[56.]
C. Vancheri, T. Ohtoshi, et al.
Human lung fibroblast-derived GM-CSF induces survival of peripheral blood eosinophils in vitro.
Am J Resp Cell and Mol Biol, 1 (1989), pp. 289-295
[57.]
R.A. Bradshaw, M. Young.
Nerve growth factor Recent developments and perspectives.
Biochem Pharmacol, 25 (1976), pp. 1.445-1.448
[58.]
pp. 1-56
[59.]
A.K.C. Li, M.J. Koroly, et al.
Nerve growth factor: acceleration of the rate of wound healing in mice.
Proc Natl Acad Sci USA, 77 (1980), pp. 4.379-4.381
[60.]
A. Bruni, E. Bigan, et al.
Interaction between nerve growth factor and lysophosphatidyilserine on rat peritoneal mast cells.
FEBS Letters, 138 (1982), pp. 190-192
[61.]
F.L. Pearce, H.L. Thompson.
Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor.
J Physiol, 372 (1986), pp. 379-393
[62.]
F. Shanahan, J. Denburg, et al.
Mast cell heterogeneity effect of neuroenteric peptides on histamine release.
J Immunol, 135 (1985), pp. 1.331-1.337
[63.]
M. Lotz, J.H. Vaughan, et al.
Effect of neuropeptides on production of inflammatory cytokines by human monocytes.
Science, 241 (1988), pp. 1.218-1.221
[64.]
J. Gauldie, M. Jordana, et al.
The release of interferon β2/BSF-2/HSF/1L-6 by the human lung fibroblast mediates the acute-phase response during lung inflammation.
Am Rev Respir Dis, 137 (1988), pp. A49
[65.]
C.P. Chiu, F. Lee.
IL-6 is a differentiation factor for MI and WEHI-3B myeloid leukemic cells.
J Immunol, 142 (1989), pp. 1.909-1.915
[66.]
C. Miyaura, C.H. Jin, et al.
Production of interleukin-6 and its relation to the macrophage differentiation of mouse myeloid leukemia cells (MI) treated with differentiation-inducing factor and lα,25-dihidroxyvitamin D3.
Biochem and Biphys Res Com, 158 (1989), pp. 660-666
[67.]
M. Jordana, J. Schulman, et al.
Heterogeneous proliferative characteristics of human adult lung fibroblast fines and clonally derived fibroblasts from control and fibrotic tissue.
Am Rev Respir Dis, 137 (1988), pp. 579-584
[68.]
L. Irving, M. Jordana, et al.
Differences in in vitro behaviour between neonatal and adult human primary and cloned lung fibroblast fines.
Am Rev Respir Dis, 135 (1987), pp. A66
[69.]
M. Jordana, J. Schulman, et al.
Spontaneous in vitro release of growth factors by human lung fibroblasts.
Am Rev Respir Dis, 137 (1988), pp. A49
[70.]
D.R. Clemmons, L.E. Underwood, et al.
Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.
J Clin Invest, 67 (1981), pp. 10-19
[71.]
D.R. Clemmons, J.J. Van Wick.
Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblast and porcine smooth muscle cells.
J Clin Invest, 75 (1985), pp. 1.914-1.918
[72.]
R.A. Seifert, S.M. Schwartz, et al.
Developmentally regulated production of platelet-derived growth factor-like molecules.
Nature, 311 (1984), pp. 669-671
[73.]
M.W. Majesty, E.P. Benditt, et al.
Expression and developmental control of platelet-derived growth factor A-chain and B-chain/sis genes in rat aortic smooth muscle cells.
Proc Natl Acad Sci USA, 85 (1988), pp. 1.524-1.528
[74.]
P. Libby, S.J.C. Warner, et al.
Production of platelet-derived growth factor-like mitogen by smooth muscle cells from human atheroma.
N Eng J Med, 318 (1988), pp. 1.493-1.498
[75.]
C. McSharry, M. Jordana, et al.
Procollagen gene expression by primary fibroblast fines derived from control and fibrotic lung tissue in humans.
Am Rev Respir Dis, 135 (1987), pp. A306
[76.]
E.C. Leroy.
Increased collagen synthesis by scleroderma skin. fibroblasts in vitro. A possible deffect in the regulation or activation of the scleroderma fibroblasts.
J Clin Invest, 54 (1974), pp. 880-889
[77.]
P.N. Graves, I.K. Weiss, et al.
Increased procollagen mRNA levels in scleroderma skin fibroblasts.
J Invest Dermatol, 80 (1983), pp. 130-132
[78.]
K. Scharffetter, B. Lankat-Buttgereit, et al.
Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization.
Eur J Clin Invest, 18 (1988), pp. 9-17
[79.]
K. Veli-Matti, M. Sandberg, et al.
Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hibridization.
J Invest Dermatol, 90 (1988), pp. 664-670
[81.]
M. Selman, M. Montano, et al.
Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis.
Thorax, 41 (1986), pp. 355-359
[82.]
R. Pérez-Tamayo, I. Montfort, et al.
Collagenolytic activity in experimental cirrhosis of the liver.
Exp Mol Pathol, 47 (1987), pp. 300-308
[83.]
R.B. Low, J. Woodcock-Mitchell, et al.
Actin content of normal and of bleomycin-fibrotic rat.
Am Rev Respir Dis, 129 (1984), pp. 311-316
[84.]
K.B. Adler, J.E. Craighead, et al.
Actin-containing cells in human pulmonary fibrosis.
Am J Pathol, 102 (1981), pp. 427-437
[85.]
Y. Kapanci, A. Assimacopoulus, et al.
Contractile interstitial cells in pulmonary alveolar septa: a possible regulator of ventilation/perfusion ratio?.: ultrastructural, immunofluorescence and in vitro studies.
J Cell Biol, 60 (1974), pp. 375-392
[86.]
R.H. Golstein, E.C. Lucy, et al.
Failure of mechanical properties in bleomycin-induced pulmonary fibrosis.
Am Rev Respir Dis, 120 (1979), pp. 67-73
[87.]
G.R. Botstein, G.K. Sherer, et al.
Fibroblast selection in scleroderma: an alternative model of fibrosis.
Arthritis Rheum, 25 (1982), pp. 189-195
[88.]
M.B. Sporn, A.B. Roberts.
Peptide growth factors and inflammation, tissue repair and cancer.
J Clin Invest, 78 (1986), pp. 329-332
[89.]
R.B. Dreising, M.L. Schawartz, et al.
Circulating immunocomplexes in the idiopathic interstitial pneumonias.
N Eng J Med, 298 (1978), pp. 353-357
[90.]
G.W. Hunninghake, J.E. Gadek, et al.
Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.
J Clin Invest, 68 (1981), pp. 259-269
[91.]
L. Reid, D. Jefferson.
Cell cultures using extracts of extracellular matrix to study growth and differentiation in mammalian cells.
Mammalian Cell Culture., pp. 239-280
[92.]
Extracellular matrix influence on gene expression.,
[93.]
M.Y. Gordon, G.P. Riley, et al.
Compartmentalization of a hemopoietic growth factor (GM-CSF) by glycosaminoglicans in the bone marrow microenvironment.
Nature, 326 (1987), pp. 403-405
[95.]
R.K. Assoian, G.R. Grotendorst, et al.
Cellular transformation by coordinated action of three peptide growth factors from human platelets.
Nature, 309 (1984), pp. 804-806
[96.]
E.B. Leof, J.A. Proper, et al.
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: A proposed model for indirect mitogenesis involving autocrine activity.
Proc Natl Acad Sci USA, 83 (1986), pp. 2.453-2.457
[97.]
Shoshan, Shmuel.
Wound healing.
International Rev Conn Tissue Res, 9 (1981), pp. 1-27
Copyright © 1989. Sociedad Española de Neumología y Cirugía Torácica
